Close

Dr Anoop Shah

MBChB PhD MPH

Associate Professor
Clinical epidemiology

Room
249

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Anoop was born in Nairobi and grew up in Kenya moving to the United Kingdom in 1998. He studied Medicine at the University of Edinburgh, graduating in 2006. His postgraduate training in internal medicine was completed in the South East of Scotland after which he joined the Centre of Cardiovascular Science at the University of Edinburgh in 2011. During this time he completed his Masters in Public Health and PhD in cardiovascular epidemiology.

His main research aims are to understand the epidemiological trends in the incidence and diagnosis of common cardiovascular pathologies. He is involved in multi-centre cluster randomized clinical trials using 'big data' to evaluate how changes in health systems can improve outcomes in patients with cardiovascular disease. He primary focus now is in global cardiovascular health especially in low- and middle-income settings.

Affiliations

Faculty of Epidemiology and Population Health
Department of Non-communicable Disease Epidemiology

Centres

Centre for Global Chronic Conditions

Research

My research interests have been in two primary areas; a) the use of routine health records in Scotland in delivering clinical trials and observational studies within cardiovascular medicine and b) evaluating environmental and chronic infections as risk factors for cardiovascular disease in low- and middle-income nations.

Research Area
Clinical trials
Complex interventions
Risk
Global Health
Discipline
Medicine
Disease and Health Conditions
Cardiovascular disease
Country
United Kingdom
India
Kenya
Region
European Union
South Asia
Sub-Saharan Africa (all income levels)

Selected Publications

CardiOvaScular Mechanisms In Covid-19: methodology of a prospective observational multimodality imaging study (COSMIC-19 study).
Alam SR; Shah ASV; Ombati KO; Nganga E; Gitau S; Makhdomi K; Chung MH; Vinayak S
2021
BMC cardiovascular disorders
The Ambulance Cardiac Chest Pain Evaluation in Scotland Study (ACCESS): A Prospective Cohort Study.
Cooper JG; Ferguson J; Donaldson LA; Black KMM; Livock KJ; Horrill JL; Davidson EM; Scott NW; Lee AJ; Fujisawa T
2021
Annals of emergency medicine
Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial.
Gallacher PJ; Miller-Hodges E; Shah ASV; Anand A; Dhaun N; Mills NL; High-STEACS Investigators
2021
JAMA internal medicine
Observed and expected serious adverse event rates in randomised clinical trials for hypertension: an observational study comparing trials that do and do not focus on older people.
Hanlon P; Corcoran N; Rughani G; Shah ASV; Mair FS; Guthrie B; Renton JP; McAllister DA
2021
The Lancet. Healthy longevity
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population.
Kimenai DM; Shah ASV; McAllister DA; Lee KK; Tsanas A; Meex SJR; Porteous DJ; Hayward C; Campbell A; Sattar N
2021
Clinical chemistry
Effect of Vaccination on Transmission of SARS-CoV-2.
Shah ASV; Gribben C; Bishop J; Hanlon P; Caldwell D; Wood R; Reid M; McMenamin J; Goldberg D; Stockton D
2021
The New England journal of medicine
Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study.
Shah ASV; Lee KK; Pérez JAR; Campbell D; Astengo F; Logue J; Gallacher PJ; Katikireddi SV; Bing R; Alam SR
2021
The Lancet regional health. Europe
See more Publications